Effect of marbofloxacin on Haemophilus parasuis nasal carriage

Veterinary Microbiology

Volumn 159, Issue 1-2, 2012, Pages 123-129

  Vilalta, Carles ^a   Galofré, Nuria ^a   Aragon, Virginia ^a,b   Pérez de Rozas, Ana María ^a,b   Fraile, Lorenzo ^a,c  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b IRTA   (Spain)

^c UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Antimicrobial treatment; Carriage; Fluoroquinolones; Haemophilus parasuis

Indexed keywords

MARBOFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM NASAL CARRIAGE; CONTROLLED STUDY; DRUG EFFECT; HAEMOPHILUS INFECTION; HAEMOPHILUS PARASUIS; LONGITUDINAL STUDY; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; ANIMAL; DRUG EFFECTS; HAEMOPHILUS INFECTIONS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NOSE; PHYSIOLOGY; RANDOMIZATION; SWINE; SWINE DISEASES; VETERINARY;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS PARASUIS; SUIDAE;

ANIMALS; ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS PARASUIS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; NOSE; RANDOM ALLOCATION; SWINE; SWINE DISEASES;

EID: 84864615809     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.03.028     Document Type: Article

References (23)

1. Appelbaum P.C., Hunter P.A. The fluoroquinolone antibacterials: past, present and future perspectives. Int. J. Antimicrob. Agents 2000, 16:5-15.
2. Banting A., Schneider M., Thomas E. Comparaison des concentrations de Marbofloxacine et de Danofloxacine dans le plasma, les secretions nasals et bronchiqus chez le jeune bovine. Congrès de la Société Française de Buiatrie-Paris, 26/27 novembre 1997, 41-42.
3. Cerdà-Cuéllar M., Naranjo J.F., Verge A., Nofrarías M., Cortey M., Olvera A., Segalés J., Aragon V. Sow vaccination modulates the colonization of piglets by Haemophilus parasuis. Vet. Microbiol. 2010, 145:315-320.
4. Clinical and Laboratory Standards Institute Guideline M31-A3. Performance for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals 2011, vol. 28(8). Available at: http://www.clsi.org/source/orders/free/m31-a3.pdf (accessed 3.11.11). 3rd ed.
5. De la Fuente A.J., Tucker A.W., Navas J., Blanco M., Morris S.J., Gutiérrez-Martín C.B. Antimicrobial susceptibility patterns of Haemophilus parasuis from pigs in the United Kingdom and Spain. Vet. Microbiol. 2007, 120:184-191.
6. Drlica K., Zhao X. Mutant selection window hypothesis updated. Clin. Infect. Dis. 2007, 44:681-688.
7. Drusano G.L., Johnson D.E., Rosen M., Standiford H.C. Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis. Antimicrob. Agents Chemother. 1993, 37:483-490.
8. Dudley M.N. Pharmacodynamics and pharmacokinetics of antibiotics with special references to the fluoroquinolones. Am. J. Med. 1991, 30:45S-50S. Review.
9. Garau J. Update on cross-resistance of fluoroquinolones. Int. J. Clin. Pract. Suppl. 2000, 115:94-98.
10. Harris D.L., Ross R.F., Switzer W.P. Incidence of certain microorganisms in nasal cavities of swine in Iowa. Am. J. Vet. Res. 1969, 30:1621-1624.
11. Marbocyl®. Marbofloxacin Reference Book. Vetoquinol Laboratory, Lure, France.
12. Martínez M., McDermott P., Walker R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Vet. J. 2006, 172:10-28.
13. McKellar Q., Gibson I., Monteiro A., Bregante M. Pharmacokinetics of enrofloxacin and danofloxacin in plasma, imflammatory exudates and bronchial secretions of calves following subcutaneous administrations. Antimicrob. Agents Chemother. 1999, 43:1988-1992.
14. McKellar Q.A., Sanchez Bruni S.F., Jones D.G. Pharmacokinetic/pharmacodynamic relationship of antimicrobial drugs used in veterinary medicine. J. Vet. Pharmacol. Ther. 2004, 27:503-514.
15. Oliveira S., Galina L., Pijoan C. Development of a PCR test to diagnose Haemophilus parasuis infections. J. Vet. Diagn. Invest. 2001, 13:495-501.
16. Olvera A., Calsamiglia M., Aragon V. Genotypic diversity of Haemophilus parasuis strains. Appl. Environ. Microbiol. 2006, 72:3984-3992.
17. Olvera A., Pina S., Macedo N., Oliveira S., Aragon V., Bensaid A. Identification of potentially virulent strains of Haemophilus parasuis using a multiplex PCR for virulence-associated autotransporters (vtaA). Vet. J. 2011, 10.1016/j.tvjl.2010.12.014.
18. Rapp-Gabrielson V., Oliveira S., Pijoan C. Haemophilus parasuis. Diseases of Swine 2006, 681-690. Iowa State University Press, Ames, Iowa. 9th ed. A.D. Leman (Ed.).
19. Roberts J.A., Kruger P., Paterson D.L., Lipman J. Antibiotic resistance-What's dosing got to do with it?. Crit. Care Med. 2008, 36:2433-2440.
20. Samuelson A., Freijd A., Jonasson J., Lindberg A.A. Turnover of nonencapsulated Haemophilus influenzae in the nasopharynges of otitis-prone children. J. Clin. Microbiol. 1995, 33:2027-2031.
21. Thomas E., Caldow G.L., Borrell D., Davot J.L. A field comparison of the efficacy and tolerance of marbofloxacin in the treatment of bovine respiratory disease. J. Vet. Pharmacol. Ther. 2001, 24:353-358.
22. Vallé, M., Woehrlé, F., Boisramé, B., 2006. Seven-year survey of susceptibility of marbofloxacin of pathogenic Pasteurelaceae strains isolated from respiratory pig infections. Poster No. 595. IPVS Congress 2006, Copenhagen.
23. Xu C., Zhang J., Zhao Z., Guo L., Zhang B., Feng S., Zhang L., Liao M. Antimicrobial susceptibility and PFGE genotyping of Haemophilus parasuis isolates from pigs in South China (2008-2010). J. Vet. Med. Sci. 2011, 73:1061-1065.